The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategyKazuomi Kario, Masaki Mogi, Satoshi Hoshide et al.|Hypertension Research|2024Cited by 341
Pre-treatment with LCZ696, an orally active angiotensin receptor neprilysin inhibitor, prevents ischemic brain damageHui‐Yu Bai, Masatsugu Horiuchi, Masaki Mogi et al.|European Journal of Pharmacology|2015Cited by 22
Akt-FOXO3a Signaling Affects Human Endothelial Progenitor Cell DifferentiationMasaki Mogi, Masatsugu Horiuchi|Hypertension Research|2008Cited by 17